Hiroko Tada
Impact in
- Microbiology top 2%
- Bacterial Infections and Vaccines
- Hematology top 5%
- Erythropoietin and Anemia Treatment
Papers in
-
- RNA Interference and Gene Delivery 12
- Protein purification and stability 6
- Co-authors
- Masaru KoyamaK. TsukamotoOsamu ShihoMasaharu SenoHidenori YamadaJun‐ichi TakanashiJunichiro FutamiMasakazu Ueda
- Journals
- Brain and Development (8 papers)Biochemical and Biophysical Research Communications (5 papers)Journal of the Neurological Sciences (3 papers)Journal of Cellular Biochemistry (3 papers)Circulation (2 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroko Tada
71 papers receiving 2.7k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Microbiology 260
- Hematology 225
- Molecular Biology 1.3k
- Immunology 362
- Pharmacy 83
Countries citing papers authored by Hiroko Tada
This map shows the geographic impact of Hiroko Tada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Tada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Tada more than expected).
Fields of papers citing papers by Hiroko Tada
This network shows the impact of papers produced by Hiroko Tada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Tada. The network helps show where Hiroko Tada may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Tada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 8 | |
| 2 | 2020 | 14 | |
| 3 | 2019 | 21 | |
| 4 | 2017 | 6 | |
| 5 | 2016 | 6 | |
| 6 | 2015 | 42 | |
| 7 | 2014 | 8 | |
| 8 | 2008 | 19 | |
| 9 | 2008 | 28 | |
| 10 | 2008 | 9 | |
| 11 | 2008 | 25 | |
| 12 | 2007 | 24 | |
| 13 | 2006 | 151 | |
| 14 | 2006 | 3 | |
| 15 | 2006 | 15 | |
| 16 | 2005 | 77 | |
| 17 | 2005 | 25 | |
| 18 | 2002 | 50 | |
| 19 | 1991 | 85 | |
| 20 | 1989 | 2 |
About Hiroko Tada
Hiroko Tada is a scholar working on Microbiology, Molecular Biology, Oncology, Infectious Diseases and Clinical Biochemistry, having authored 71 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (12 papers), Infectious Encephalopathies and Encephalitis (10 papers), Pancreatic function and diabetes (8 papers), Peptidase Inhibition and Analysis (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Protein purification and stability (6 papers), Virus-based gene therapy research (5 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Microbiology (260 citations), Hematology (225 citations), Molecular Biology (1.3k citations), Immunology (362 citations) and Pharmacy (83 citations). Hiroko Tada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Masaru Koyama, K. Tsukamoto, Osamu Shiho, Masaharu Seno, Hidenori Yamada, Jun‐ichi Takanashi, Junichiro Futami, Masakazu Ueda, A. James Barkovich and Megumi Kosaka. Their work appears in journals such as Brain and Development, Biochemical and Biophysical Research Communications, Journal of the Neurological Sciences, Journal of Cellular Biochemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.